SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Corium International, Inc. (CORI)

Add CORI Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 11/16/2015 2:18:43 PM - Followers: 1 - Board type: Free - Posts Today: 0
Corium International, Inc.
235 Constitution Drive
Menlo Park, CA 94025
United States
Phone: 650-298-8255
Fax: 650-298-8012

Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CORI News: Corium to Present at Dawson James Securities Growth Stock Conference 10/13/2016 08:00:00 AM
CORI News: Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Memantine 08/24/2016 08:00:00 AM
CORI News: Quarterly Report (10-q) 08/12/2016 04:09:56 PM
CORI News: Corium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights 08/04/2016 04:01:00 PM
CORI News: Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016 07/28/2016 08:00:00 AM
#1   $CORI recent news/filings stocktrademan 11/16/15 02:18:43 PM